Active Ingredient History

  • Now
Sumanirole (PNU-95,666) is a highly selective D2 receptor full agonist, the first of its kind to be discovered. It was developed for the treatment of Parkinson's disease and restless leg syndrome. While it has never been approved for medical use it is a highly valuable tool compound for basic research to identify neurobiological mechanisms that are based on a dopamine D2-linked (vs. D1-, D3-, D4-, and D5-linked) mechanism of action.   Wikipedia

  • SMILES: CN[C@H]1CN2C(=O)Nc3cccc(C1)c23
  • Mol. Mass: 203.25
  • ALogP: 0.47
  • ChEMBL Molecule:
More Chemistry
5,6-dihydro-5-(methylamino)-4h-imidazo(4,5,1ij)-quinolin-2(1h)-one (z)-2-butenedioate | pnu-95666 | pnu-95666e | sumanirole | u 95666e | u-95666e


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue